Back to search

Article

Sustained Response with Dose Reduced Selpercatinib in a Pediatric Patient with Metastatic NCOA4-RET Fusion Papillary Thyroid Carcinoma

2023-01-23

Abstract excerpt

Understanding the molecular landscape of papillary thyroid carcinoma (PTC), the most common thyroid cancer in children, creates additional therapeutic approaches. RET gene rearrangements are observed in pediatric PTC and selective inhibition of RET is now possible with specific tyrosine kinase inhibitors designed to target diverse RET -activating mutations. We present a 13-year-old female with radioactive iodine...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
735f3027-1e17-5b4b-bd7e-c4deca2690c1
DOI
10.22541/au.167446630.05113063/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Sustained Response with Dose Reduced Selpercatinib in a Pediatric Patient with Metastatic NCOA4-RET Fusion Papillary Thyroid CarcinomaDOI 10.22541/au.167446630.05113063/v1
NTRK and RET fusion–directed therapy in pediatric thyroid cancer yields a tumor response and radioiodine uptakeSemantic proximity
Papillary and Follicular Thyroid Cancer in children and adolescents: Current approach and future directions.Semantic proximity
Mutational Analysis in Pediatric Thyroid Cancer and Correlations with Age, Ethnicity, and Clinical Presentation.Semantic proximity
Application of genomics to identify therapeutic targets in recurrent pediatric papillary thyroid carcinoma.Semantic proximity
FDA Approval Summary: Selpercatinib for the Treatment of Lung and Thyroid Cancers with RET Gene Mutations or Fusions.Semantic proximity
Selpercatinib in the treatment of thyroid cancer.Semantic proximity
RET, NTRK, ALK, BRAF, and MET Fusions in a Large Cohort of Pediatric Papillary Thyroid Carcinomas.Semantic proximity
Integrated DNA and RNA sequencing reveals targetable alterations in metastatic pediatric papillary thyroid carcinoma.Semantic proximity
Pediatric, Adolescent, and Young Adult Thyroid Carcinoma Harbors Frequent and Diverse Targetable Genomic Alterations, Including Kinase Fusions.Semantic proximity
Mutational analysis using next generation sequencing in pediatric thyroid cancer reveals BRAF and fusion oncogenes are common.Semantic proximity
The clinical aspect of NTRK-fusions in pediatric papillary thyroid cancer.Semantic proximity
NTRK-fusions in pediatric thyroid tumors: Current state and future perspectives.Semantic proximity
Select a neighboring publication to make it the new centre.